TREM2 loss-of-function mutations lead to significant lysosomal dysfunction and downregulated expression of genes involved in lipid metabolism in induced pluripotent stem cell (iPSC)-derived microglia from patients with Nasu-Hakola disease (NHD) (57). This evidence concerns the gene TREM2 and Nasu-Hakola disease.